Publication | Open Access

Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases

Neuro-oncologyHealth SciencesRadiation TherapyMelanoma Brain MetastasesMedicineMelanomaCancer TreatmentOncologyRadiation OncologyStereotactic RadiosurgeryRadiologyBraf Inhibitors